title: Making sense of cephalosporin and amoxicillin/clavulanate susceptibility testing for uropathogens.
authors.affiliation: Kaiser Permanente Northwest, Portland, Oregon.
authors.forename: Hien M
authors.initials: HM
authors.lastname: Nguyen
authors.affiliation: Kaiser Permanente Northwest, Portland, Oregon.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Labreche
authors.affiliation: Infectious Diseases Section, VA Greater Los Angeles Healthcare System and the David Geffen School of Medicine at the University of California.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Graber
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004755:Enterobacteriaceae / Q000187:drug effects*; D013293:Enterococcus faecalis / Q000187:drug effects*; D006801:Humans; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D014552:Urinary Tract Infections / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents